Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry Muller-Oerlinghausen B; Berghofer A; Ahrens BCan J Psychiatry 2003[Aug]; 48 (7): 433-9The suicide-related mortality among patients with affective disorders is approximately 30 times higher, and overall mortality 2 to 3 times higher, than suicide-related mortality in the general population. Lithium has demonstrated possibly specific antisuicidal effects apart from its prophylactic efficacy: it significantly reduces the high excess mortality of patients with affective disorders. To date, suicide-prevention effects have not been shown for antidepressant or anticonvulsant long-term treatment. Clozapine appears to reduce the suicide rate in schizophrenia patients. Against this background, guidelines and algorithms for selecting an appropriate prophylactic strategy for affective disorders should consider the presence of suicidality in patient history. Appropriate lithium prophylaxis prevents approximately 250 suicides yearly in Germany, although lithium salts are infrequently prescribed within the National Health Scheme (specifically, to 0.06% of the population). Rational treatment strategies most likely would demand that prescription rates be about 10 times higher.|*Suicide Prevention[MESH]|Algorithms[MESH]|Antimanic Agents/adverse effects/*therapeutic use[MESH]|Bipolar Disorder/*drug therapy/mortality[MESH]|Cause of Death[MESH]|Clinical Trials as Topic[MESH]|Depressive Disorder, Major/*drug therapy/mortality[MESH]|Germany/epidemiology[MESH]|Humans[MESH]|Lithium Compounds/adverse effects/*therapeutic use[MESH]|Practice Guidelines as Topic[MESH]|Psychotic Disorders/*drug therapy/mortality[MESH]|Suicide/statistics & numerical data[MESH]|Survival Analysis[MESH] |